Standard-of-Care Treatment for Rheumatoid Arthritis Lags for Minority Groups

(MedPage Today) — Use of disease-modifying anti-rheumatic drugs (DMARDs) for rheumatoid arthritis (RA) was markedly lower among all major racial-ethnic minority groups in the U.S. compared with white patients, analysis of federal survey data indicated…